Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
3.
Am J Dermatopathol ; 45(9): 646-649, 2023 Sep 01.
Article in English | MEDLINE | ID: mdl-37506270

ABSTRACT

ABSTRACT: Xanthelasma palpebrarum represent the most common subtype of cutaneous plane xanthomas. Xanthosiderohistiocytosis is considered a rare variant of xanthoma disseminatum, with only 4 cases reported to date. We report the case of a man with progressive pigmented lesions on the 4 eyelids that could correspond to hemosiderotic xanthelasmas or a localized variant of xanthosiderohistiocytosis.


Subject(s)
Connective Tissue Diseases , Eyelid Diseases , Hemosiderosis , Skin Neoplasms , Xanthomatosis , Male , Humans , Eyelid Diseases/pathology , Eyelids , Xanthomatosis/pathology
7.
Am J Dermatopathol ; 45(3): 176-179, 2023 Mar 01.
Article in English | MEDLINE | ID: mdl-36728290

ABSTRACT

ABSTRACT: Antitumor necrosis factor therapies have shown to produce a broad range of cutaneous eruptions. We report the case of a patient under adalimumab biosimilar treatment for a punctate inner choroidopathy who developed a cutaneous eruption on sun-exposed areas that showed a diffuse dermal neutrophilic infiltrate consistent with a Sweet-like neutrophilic dermatosis and some features of autoimmunity.


Subject(s)
Biosimilar Pharmaceuticals , Dermatitis , Sweet Syndrome , Humans , Skin/pathology , Sweet Syndrome/chemically induced , Sweet Syndrome/drug therapy , Adalimumab/adverse effects , Biosimilar Pharmaceuticals/adverse effects , Autoimmunity , Dermatitis/pathology
11.
Dermatol Ther ; 35(11): e15806, 2022 11.
Article in English | MEDLINE | ID: mdl-36070222

ABSTRACT

Extensive subtypes of alopecia areata (AA) (totalis, universalis, or multifocal) still have no approved and effective treatments in Europe, although Janus kinase inhibitors, such as baricitinib, are promising treatments that have been recently approved by the FDA. Nowadays, the higher costs and the lower experience with Janus kinase inhibitors, provide more difficulties in its accessibility. On the other hand, different corticosteroids regimens have been evaluated with conflicting results from decades. In 2016, a new regimen of mini pulse corticosteroid therapy with oral dexamethasone (MPCT-OD) 0.1mg/kg/day twice per week for adult patients with alopecia areata totalis or universalis, was reported to be effective with a lower rate of adverse effects. We performed a retrospective and multicentric study to collect data from patients with extensive forms of alopecia areata who had received MPCTOD (0.1 mg/kg/day twice weekly of dexamethasone) for at least 24 weeks. We included adult patients (≥18 years) with extensive forms of AA (SALT index ≥ 10) that did not respond to previous treatments. Variables including epidemiological and clinical data were recorded. Therapeutic response was assessed through the % change in SALT score (from 0 to 100%) and the changes in eyebrow and eyelash alopecia index (EBA, ELA) from baseline to 24 weeks after the beginning of the treatment. Dexamethasone dosage, duration of the treatment, time until response, time to relapse, adverse effects, and discontinuation were also recorded.


Subject(s)
Alopecia Areata , Janus Kinase Inhibitors , Adult , Humans , Alopecia Areata/diagnosis , Alopecia Areata/drug therapy , Alopecia Areata/chemically induced , Janus Kinase Inhibitors/adverse effects , Retrospective Studies , Dexamethasone/adverse effects , Alopecia/drug therapy , Treatment Outcome , Adrenal Cortex Hormones/therapeutic use
14.
Dermatol Pract Concept ; 12(1): e2022080, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35223189

ABSTRACT

INTRODUCTION: Frontal fibrosing alopecia (FFA) is a form of primary lymphocytic scarring alopecia characterized by a progressive recession of the fronto-temporal hairline. Although the clinical presentation of FFA is very typical, biopsy for histopathological examination is still recommended to confirm the diagnosis. Currently, a growing number of skin and mucosal inflammatory diseases are diagnosed with modern noninvasive techniques such as dermoscopy without the necessity of a biopsy. OBJECTIVES: The International Dermoscopy Society (IDS) aimed to test the ability of its members to diagnose classic FFA through clinical and dermoscopic parameters and to compare acquired data to the largest cohort studies published since 1994. METHODS: This is an observational, cross-sectional study describing patient demographics, clinical presentation and diagnostic tools used in a sample of FFA patients collected by IDS members. A literature search was then performed using Pubmed to review studies reporting more than 100 cases. RESULTS: IDS members submitted 188 cases demonstrating a predominant female population (98.4%). In 71.8% of the cases, the clinical presentation and the trichoscopic findings allowed for the diagnosis. Out of 24 revised studies, 13 showed that clinical and trichoscopic features were decisive for the diagnosis in almost all cases. CONCLUSIONS: Demographic and clinical data of our cohort were mostly comparable to previous reported data on FFA. The relevant role of the clinical and trichoscopic features in diagnosing FFA was confirmed by our study and the reviewed literature. Trichoscopy could be considered a worldwide-acknowledged non-invasive technique for the diagnosis of FFA.

15.
J Am Acad Dermatol ; 86(4): 774-781, 2022 04.
Article in English | MEDLINE | ID: mdl-34695527

ABSTRACT

BACKGROUND: Limited data on dermatoscopy of nodular/plaque-type T-/B-cell primary cutaneous lymphomas (PCLs) is available. OBJECTIVE: To describe dermatoscopic features of nodular/plaque-type PCLs, comparing them with those of clinical mimickers (pseudolymphomas, tumors, and inflammatory lesions) and investigating possible differences according to histologic subtypes. METHODS: Participants were invited to join this retrospective, multicenter case-control study by submitting histologically/immunohistochemically confirmed instances of nodular/plaque-type PCLs and controls. Standardized assessments of the dermatoscopic images and comparative analyses were performed. RESULTS: A total of 261 lesions were included (121 PCLs and 140 controls). Orange structureless areas were the strongest PCL dermatoscopic predictor on multivariate analysis compared with tumors and noninfiltrative inflammatory dermatoses. On the other hand, a positive association was found between PCLs and either unfocused linear vessels with branches or focal white structureless areas compared with infiltrative inflammatory dermatoses, whereas white lines were predictive of PCLs over pseudolymphomas. Differences in the vascular pattern were also seen between B- and T-cell PCLs and among B-cell PCL subtypes. LIMITATIONS: Retrospective design and the lack of a dermatoscopic-pathologic correlation analysis. CONCLUSION: Nodular/plaque-type PCLs display dermatoscopic clues, which may partially vary according to histologic subtype and whose diagnostic relevance depends on the considered clinical differential diagnoses.


Subject(s)
Breast Neoplasms , Lymphoma, B-Cell , Lymphoma, T-Cell, Cutaneous , Pseudolymphoma , Skin Neoplasms , Case-Control Studies , Dermoscopy , Female , Humans , Lymphoma, B-Cell/diagnostic imaging , Pseudolymphoma/diagnostic imaging , Retrospective Studies , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...